Follow the Leader: 2 Biopharma Stocks Showing Relative Strength in 2025 [Yahoo! Finance]
Gilead Sciences (NasdaqGS:GILD) Advances HIV Treatment With Promising Lenacapavir And Biktarvy Data [Yahoo! Finance]
GILD Data on Once-Yearly Lenacapavir for HIV Prevention Positive [Yahoo! Finance]
Vantis Health completes €10m funding round to advance primary care [Yahoo! Finance]
Gilead Presents New HIV Treatment and Cure Research Data at CROI 2025, Including an Investigational Long-Acting, Twice-Yearly Therapy Option